Get the Stockscreener App
92.73
0.72%
-0.67
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $92.73, with a volume of 924.24K.
It is down -0.72% in the last 24 hours and up +1.74% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$93.40
Open:
$92.69
24h Volume:
924.24K
Relative Volume:
0.74
Market Cap:
$10.76B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
39.46
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
+2.15%
1M Performance:
+1.74%
6M Performance:
+1.88%
1Y Performance:
-20.09%
1-Day Range:
$91.39
$93.54
1-Week Range:
$91.03
$95.79
52-Week Range:
$81.36
$128.28
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
92.73 | 10.59B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Why Revvity Inc. is moving todayPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
Can Revvity Inc. stock sustain institutional flowsJuly 2025 Opening Moves & Daily Momentum Trading Reports - newser.com
Can Revvity Inc. stock sustain breakout momentumTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Why analysts remain bullish on Revvity Inc. stock2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Why Revvity Inc. stock remains stableJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
What Fibonacci levels say about Revvity Inc. rebound2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Is Revvity Inc. (PKN) stock included in top ETFsJuly 2025 Earnings & Safe Capital Growth Tips - newser.com
Is Revvity Inc. stock dividend growth reliableMarket Trend Summary & High Conviction Buy Zone Alerts - newser.com
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more - MSN
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more (BX:NYSE) - Seeking Alpha
Relative strength of Revvity Inc. in sector analysisEarnings Risk Report & Verified Swing Trading Watchlists - newser.com
Pattern recognition hints at Revvity Inc. upside2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
How Revvity Inc. stock reacts to fiscal policiesJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Why Revvity Inc. stock remains a top recommendation2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
What earnings revisions data tells us about Revvity Inc.Trade Ideas & AI Optimized Trading Strategy Guides - newser.com
Can Revvity Inc. stock withstand economic slowdownMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Why Revvity Inc. stock could see breakout soonWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
Developing predictive dashboards with Revvity Inc. dataJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Can trapped investors hope for a rebound in Revvity Inc.Trade Entry Summary & Detailed Earnings Play Strategies - newser.com
Is Revvity Inc. (PKN) stock safe for risk averse investorsSwing Trade & Accurate Intraday Trading Signals - newser.com
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):